Lundbeck
HLUN-B.CO
#2494
Rank
$5.94 B
Marketcap
$6.22
Share price
2.08%
Change (1 day)
29.86%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Lundbeck (HLUN-B.CO) - Total debt

Total debt on the balance sheet as of September 2024 : $0.62 Billion USD

According to Lundbeck 's latest financial reports the company's total debt is $0.62 Billion USD. A companyโ€™s total debt is the sum of all current and non-current debts.

Lundbeck - Total debt on balance sheet (from 2009 to 2024)

Total debt by year

Year Total debt Change
2023-12-31$0.61 B-23.48%
2022-12-31$0.80 B-0.85%
2021-12-31$0.81 B-37.87%
2020-12-31$1.30 B-9.18%
2019-12-31$1.43 B
2018-12-31N/A-100%
2017-12-31$9.18 M-96.58%
2016-12-31$0.26 B-51.41%
2015-12-31$0.55 B1.19%
2014-12-31$0.54 B36.53%
2013-12-31$0.39 B18.14%
2012-12-31$0.33 B1.2%
2011-12-31$0.33 B-2.89%
2010-12-31$0.34 B-48.55%
2009-12-31$0.66 B87.23%
2008-12-31$0.35 B-1.97%
2007-12-31$0.36 B43.55%
2006-12-31$0.25 B317.99%
2005-12-31$60.78 M-18.62%
2004-12-31$74.69 M